Thompson Investment Management, Inc. Astrazeneca PLC Transaction History
Thompson Investment Management, Inc.
- $718 Million
- Q3 2025
A detailed history of Thompson Investment Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 798 shares of AZN stock, worth $71,341. This represents 0.01% of its overall portfolio holdings.
Number of Shares
798
Previous 1,321
39.59%
Holding current value
$71,341
Previous $92,000
33.7%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,502Shares Held
500MCall Options Held
5.64MPut Options Held
3.2M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...